BioCentury
ARTICLE | Company News

Provalis diabetes test approved

August 23, 2000 7:00 AM UTC

Provalis (LSE:PRO) received 510K approval to market its Glycosal point-of-care diabetes monitoring test in the U.S. The test measures HbA1c, a measure of long-term glucose levels. PRO was up 12p (59 p...